Episode Details
Back to Episodes
EMSP 2026. Progress, Hope and Real Challenges in Multiple Sclerosis
Description
The EMSP 2026 Conference in Berlin highlighted how much is currently evolving in multiple sclerosis (MS) – from improved diagnostics and emerging therapies to long-overdue topics like fatigue, PIRA, and menopause.
In this episode, I share my personal insights from Day 1 on site and summarize the key developments from Day 2. We explore why the "MS iceberg" is still widely misunderstood, how new approaches like CAR-T and stem cell therapy are shaping the future, and why access to care across Europe remains a major challenge.
👉 Read the full blog article:
https://ms-perspektive.de/en/164-emsp
🔎 What we cover in this episode
- Personal impressions from EMSP 2026 in Berlin
- Patient stories: MS and NMOSD
- McDonald Criteria 2024 and improved MS diagnosis
- The "MS iceberg" and invisible symptoms like fatigue
- Poster insights: fatigue as a key burden in MS
- MS Selfie and decision support tools for immunotherapies
- CAR-T cell therapy and stem cell therapy
- Menopause and MS
- PIRA (Progression Independent of Relapse Activity)
- Access to MS care across Europe
🔗 Mentioned resources & episodes
👉 Barbara Willekens on CAR-T cell therapy
👉 Christoph Heesen on stem cell therapy
👉 Roland Martin on aHSCT
👉 Riley Bove on menopause & MS
👉 Gavin Giovannoni on PIRA
👉 Fatigue article
👉 Article: From Fatigue to Focus (ECTRIMS insights)
👉 MS Selfie Microsite: https://msselfie.co.uk/
👉 McDonald Criterie 2024
👉 Full blog article:
https://ms-perspektive.de/en/164-emsp
---
See you soon and try to make the best out of your l